Cargando…

Holland-Frei cancer medicine /

"The original reference resource for medical oncologists, radiation oncologists, internists, and allied specialties involved in the treatment of cancer patients, Holland-Frei Cancer Medicine covers the ever-expanding field of current cancer science and clinical oncology practice. In this new ni...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Bast, Robert C., Jr. (Robert Clinton), 1943- (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hoboken, New Jersey : John Wiley & Sons, Inc., [2017]
Edición:Ninth edition.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • List of contributors
  • Preface
  • Acknowledgments
  • Part 1: INTRODUCTION
  • 1 Cardinal manifestations of cancer
  • 2 Biological hallmarks of cancer
  • Part 2: TUMOR BIOLOGY
  • 3 Molecular biology, genomics, proteomics, and mouse models of human cancer
  • 4 Oncogenes
  • 5 Tumor suppressor genes
  • 6 Epigenetic contributions to human cancer
  • 7 Cancer genomics and evolution
  • 8 Chromosomal aberrations in cancer
  • 9 MicroRNA expression in cancer
  • 10 Aberrant signaling pathways in cancer
  • 11 Differentiation therapy
  • 12 Cancer stem cells
  • 13 Cancer and cell death
  • 14 Cancer cell immortality: targeting telomerase
  • 15 Cancer metabolism
  • 16 Modeling therapy of late or early-stage metastatic disease in mice
  • 17 Tumor angiogenesis
  • Part 3: QUANTITATIVE ONCOLOGY
  • 18 Cancer bioinformatics
  • 19 Systems biology and genomics
  • 20 Statistical innovations in cancer research
  • 21 Biomarker-based clinical trial design in the era of genomic medicine
  • 22 Clinical informatics
  • Part 4: CARCINOGENESIS
  • 23 Chemical carcinogenesis
  • 24 Endocrine and genetic bases of hormone-related cancers
  • 25 Ionizing radiation
  • 26 Ultraviolet radiation carcinogenesis
  • 27 Inflammation and cancer
  • 28 RNA tumor viruses
  • 29 Herpesviruses
  • 30 Papillomaviruses and cervical neoplasia
  • 31 Hepatitis viruses and hepatoma
  • 32 Parasites
  • Part 5: EPIDEMIOLOGY, PREVENTION AND DETECTION
  • 33 The burden of cancer worldwide: current and future perspectives
  • 34 Cancer epidemiology
  • 35 Behavioral approaches to cancer prevention
  • 36 Diet and nutrition in the etiology and prevention of cancer
  • 37 Chemoprevention of cancer
  • 38 Cancer screening and early detection
  • Part 6: CLINICAL DISCIPLINES
  • 39 Nexgen pathology: predicting clinical course and targeting disease causation
  • 40 Molecular diagnostics in cancer
  • 41 Principles of imaging
  • 42 Interventional radiology for the cancer patient
  • 43 Principles of surgical oncology
  • 44 Principles of radiation oncology
  • 45 Principles of medical oncology
  • 46 Palliative care and pain management
  • 47 Principles of psycho-oncology
  • 48 Principles of cancer rehabilitation medicine
  • 49 Integrative oncology in cancer care
  • 50 Health services research
  • Part 7: INDIVIDUALIZED TREATMENT
  • 51 Personalized medicine in oncology drug development
  • Part 8: CHEMOTHERAPY
  • 52 Preclinical and early clinical development of chemotherapeutic drugs, mechanism-based agents and biologics
  • 53 Tumor growth kinetics
  • 54 Principles of dose, schedule, and combination therapy
  • 55 Pharmacology
  • 56 Folate antagonists
  • 57 Pyrimidine and purine antimetabolites
  • 58 Alkylating agents and platinum antitumor compounds
  • 59 DNA topoisomerase targeting drugs
  • 60 Agents targeting microtubules and mitotic processes
  • 61 Endocrine therapy for hormone receptor-positive breast cancer
  • 62 Drug resistance and its clinical circumvention
  • Part 9: BIOLOGICAL AND GENE THERAPY
  • 63 Cytokines, interferons, and hematopoietic growth factors
  • 64 Monoclonal serotherapy
  • 65 Vaccines and immunostimulants
  • 66 Cell-based cancer immunotherapy
  • 67 Cancer immunotherapy
  • 68 Cancer gene therapy
  • 69 Cancer nanotechnology
  • 70 Hematopoietic cell transplantation
  • Part 10: SPECIAL POPULATIONS
  • 71 Principles of pediatric oncology
  • 72 Cancer and pregnancy
  • 73 Cancer and aging
  • 74 Disparities in cancer care
  • 75 Neoplasms in acquired immunodeficiency syndrome
  • 76 Cancer survivorship: new challenge in cancer medicine
  • Part 11: DISEASE SITES
  • 77 Primary and metastatic neoplasms of the brain in adults
  • 78 Neoplasms of the eye
  • 79 Neoplasms of the endocrine glands: pituitary neoplasms
  • 80 Neoplasms of the thyroid
  • 81 Neoplasms of the adrenal cortex
  • 82 Tumors of the diffuse neuroendocrine and gastroenteropancreatic system
  • 83 Neoplasms of the head and neck
  • 84 Cancer of the lung
  • 85 Malignant pleural mesothelioma
  • 86 Thymomas and thymic tumors
  • 87 Tumors of the heart and great vessels
  • 88 Primary germ cell tumors of the thorax
  • 89 Neoplasms of the esophagus
  • 90 Carcinoma of the stomach
  • 91 Primary neoplasms of the liver
  • 92 Gallbladder and bile duct cancer
  • 93 Neoplasms of the exocrine pancreas
  • 94 Neoplasms of the small intestine, vermiform appendix, and peritoneum, and carcinoma of the colon and rectum
  • 95 Neoplasms of the anus
  • 96 Renal cell carcinoma
  • 97 Urothelial cancer
  • 98 Neoplasms of the prostate
  • 99 Tumors of the penis and the urethra
  • 100 Testis cancer
  • 101 Neoplasms of the vulva and vagina
  • 102 Neoplasms of the cervix
  • 103 Endometrial cancer
  • 104 Epithelial ovarian, fallopian tube, and peritoneal cancer
  • 105 Nonepithelial ovarian malignancies
  • 106 Molar pregnancy and gestational trophoblastic neoplasia
  • 107 Gynecologic sarcomas
  • 108 Neoplasms of the breast
  • 109 Malignant melanoma
  • 110 Other skin cancers
  • 111 Bone tumors
  • 112 Soft tissue sarcomas
  • 113 The myelodysplastic syndrome
  • 114 Acute myeloid leukemia in adults: mast cell leukemia and other mast cell neoplasms
  • 115 Chronic myeloid leukemia
  • 116 Acute lymphoblastic leukemia
  • 117 Chronic lymphocytic leukemia
  • 118 Hodgkin lymphoma
  • 119 Non-Hodgkin's lymphoma
  • 120 Mycosis fungoides and Sézary syndrome
  • 121 Plasma cell tumors
  • 122 Myeloproliferative neoplasms: essential thrombocythemia, primary myelofibrosis, and polycythemia vera
  • Part 12: MANAGEMENT OF CANCER COMPLICATIONS
  • 123 Neoplasms of unknown primary site
  • 124 Anorexia and cachexia
  • 125 Antiemetic therapy
  • 126 Neurologic complications of cancer
  • 127 Dermatologic complications of cancer chemotherapy
  • 128 Skeletal complications
  • 129 Hematologic complications and blood bank support
  • 130 Coagulopathic complications of cancer patients
  • 131 Urologic complications
  • 132 Cardiac complications
  • 133 Respiratory complications
  • 134 Gastrointestinal and hepatic complications in cancer patients
  • 135 Oral complications of cancer and their treatment
  • 136 Gonadal complications
  • 137 Sexual dysfunction
  • 138 Endocrine complications and paraneoplastic syndromes
  • 139 Infections in patients with cancer
  • 140 Oncologic emergencies
  • Part 13: THE FUTURE OF ONCOLOGY
  • 141 A vision for twenty-first century healthcare
  • Index.